Business
Guardant Health to Participate in Upcoming June Investor Conferences
PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be
About this update from Guardant Health, Inc.
[{"type":"text","content":" PALO ALTO, Calif.--(BUSINESS WIRE)--\nGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.\n\n\n\nWilliam Blair 43rd Annual Growth Stock Conference in Chicago, IL\nPresentation on Tuesday, June 6th at 4:40 p.m. Central Time\n\n\n\n\nGoldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA\nFireside Chat on Monday, June 12th at 4:00 p.m. Pacific Time\n\n\n\nInterested parties may access live and archived webcasts of the sessions on the “Investors” section of the company website at: www.guardanthealth.com.\n\n\nAbout Guardant Health\n\n\nGuardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantINFINITY™ tests for advanced-stage cancer, and Guardant Reveal™ for early-stage cancer. The Guardant Health screening portfolio, including the commercially launched Shield™ test, aims to address the needs of individuals eligible for cancer screening.\n\nView source version on businesswire.com: https://www.businesswire.com/news/home/20230525005834/en/\n\nInvestor Contact:\nAlex Kleban\[email protected]\n+1 657-254-5417\n\n\nMedia Contact:\nMichael Weist\[email protected]\n+1 317-371-0035\n\n\nSource: Guardant Health, Inc.","length":3535,"tagName":"div"}]